Acute psychoses in patients with psoriatic arthritis during treatment with sulfasalazine
Jajić, Z.; Jajić, I.
Reumatizam 46(1): 43-44
1998
ISSN/ISBN: 0374-1338 PMID: 9921009 Document Number: 493684
We present a case of hastily progress of acute psychosis in a woman patient who has been treating with Sulphasine because of psoriatic arthritis. The medicine has been taken for a short time (one month) and in low doses. We bring out this instructive case, which shows a possibility of development of one severe and unusual complication, never noted down in literature.
Document emailed within 1 workday
Related Documents
Lindqvist, U.; Wernroth, M.-L.; Husmark, T.; Larsson, P.; Geijer, M.; Teleman, A.; Theander, E.; Alenius, G.-M. 2017: DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. the Swedish Early Psoriatic Arthritis Cohort Clinical and Experimental Rheumatology 35(6): 936-942Cohen, M.R.; Reda, D.J.; Clegg, D.O. 1999: Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies Journal of Rheumatology 26(8): 1752-1756
Korthals-de Bos, I.; Van Tulder, M.; Boers, M.; Verhoeven, A.C.; Adèr, H.J.; Bibo, J.; Boonen, A.; Van Der Linden, S. 2004: Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone Journal of Rheumatology 31(9): 1709-1716
Salvarani, C.; Lo Scocco, G.; Macchioni, P.; Cremonesi, T.; Rossi, F.; Mantovani, W.; Battistel, B.; Bisighini, G.; Portioli, I. 1995: Prevalence of psoriatic arthritis in Italian psoriatic patients Journal of Rheumatology 22(8): 1499-1503
Badalov, N.G.; Tupitsyn, N.N.; Grigor'eva, V.D. 2001: Keratinocyte immunophenotypes in patients with psoriatic arthritis and their changes after treatment with deresinated naphthalan Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 32-34
Ichikawa, Y.; Takaya, M. 1987: Sulfasalazine therapy in patients with rheumatoid arthritis Ryumachi 27(1): 10-15
Badalov, N.G.; Tupitsyn, N.N.; Grigor'eva, V.D. 2001: Phenotype characteristics of skin dendritic cells in patients with psoriatic arthritis during the treatment with deresinated naphthalan Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 29-32
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Mundo, A.; Pedone, V.; Lamanna, G.; Cervini, C. 1997: Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis La Clinica Terapeutica 148(1-2): 7-13
Madland, T.Magne.; Björkkjaer, T.; Brunborg, L.Anne.; Fröyland, L.; Berstad, A.; Brun, J.G. 2006: Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil Journal of Rheumatology 33(2): 307-310
Theiss, B. 1971: Are there typical skin manifestations in psoriatic arthritis and psoriatic spondylarthritis? Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 22(2): 63-68
Patrizi, A.; Venturi, M.; Scorzoni, R.; Pazzaglia, M.; Malavolta, N.; Bardazzi, F. 2014: Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(2): 177-184
Soejima, M.; Kawaguchi, Y.; Hara, M.; Kamatani, N. 2008: Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis Journal of Rheumatology 35(4): 724
Martin, B.C.; Thomas, L.W.; Dann, F.J. 2017: Apremilast for the treatment of psoriatic arthritis Dermatology Online Journal 23(2)
Sukenik, S.; Giryes, H.; Halevy, S.; Neumann, L.; Flusser, D.; Buskila, D. 1994: Treatment of psoriatic arthritis at the Dead Sea Journal of Rheumatology 21(7): 1305-1309
Shapiro, D.L.; Masci, J.R. 1996: Treatment of HIV associated psoriatic arthritis with oral gold Journal of Rheumatology 23(10): 1818-1820
McLaughlin, M.; Ostör, A. 2014: Early treatment of psoriatic arthritis improves prognosis Practitioner 258(1777): 21-24; 3
Gladman, D.D. 1992: Psoriatic arthritis: recent advances in pathogenesis and treatment Rheumatic Diseases Clinics of North America 18(1): 247-256
Frediani, B.; Allegri, A.; Falsetti, P.; Storri, L.; Bisogno, S.; Baldi, F.; Filipponi, P.; Marcolongo, R. 2001: Bone mineral density in patients with psoriatic arthritis Journal of Rheumatology 28(1): 138-143
Zaghi, D.; Krueger, G.G.; Callis Duffin, K. 2012: Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis Journal of Drugs in Dermatology: Jdd 11(2): 160-167